Partners Agnes Juang, Ph.D., and Daniel A. Kamkar co-authored, “The Complex Litigation Surrounding Remicade And Its Biosimilar Challengers” which was published in Biosimilar Development.
Excerpt: Janssen Biotech Inc. and Celltrion Healthcare are engaged in a series of complex litigations over Janssen’s arthritis biologic medicine Remicade (infliximab) and Celltrion’s biosimilar.
Subscribe for News and Updates
